Last year, Rutger Zietsma was named as one of In Vivo’s Rising Leaders thanks in part to his work driving the development and implementation of the NeuroMotor Pen, a handheld device that can be easily used by patients and clinicians to detect a variety of neurological abnormalities. At the time, Zietsma discussed the importance of selecting the right individuals to bring on board for a fledgling business and how the impact of a poor decision can be severe.
Good decisions have clearly been made, though, as in the time since, Zietsma’s company, Manus Neurodynamica, has reached new heights....
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?